Evidence map›Paper›PMID 23753231›Full record

ReviewJournal of intensive care medicine

Cytomegalovirus pneumonia in hematopoietic stem cell recipients.

Giovanna Travi, Steven A Pergam

Abstract readReview
In one paragraph

Review in Journal of intensive care medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed.

  1. Trial
  2. Review
  3. Observational
  4. Article
  5. Article
  6. Impact of multiplexed respiratory viral panels on infection control measures and antimicrobial stewardship: a review of the literature.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2022
    Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Detection ofJournal of clinical and diagnostic research : JCDR · 2017
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Giovanna TraviDepartment of Infectious Diseases, AO Ospedale Niguarda Cà Granda, Milan, Italy.
Steven A PergamVaccine and Infectious Diseases and Clinical Research Divisions, Fred Hutchinson Cancer Research Center, Seattle, WA, USA Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA spergam@fhcrc.org.

Funding

Natural Killer Cell Receptor Diversity and CMV in Hematopoietic Cell TransplantatK23HL096831 · NHLBI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PERGAM, STEVEN AARON · 2009 to 2013
$663k
NHLBI NIH HHS K23 HL096831NHLBI NIH HHS K23HL096831
6 · The paper itself

Abstract

Cytomegalovirus (CMV) is a frequently encountered infection following hematopoietic cell transplantation, and tissue invasive pneumonia is a dreaded complication of the virus in this population. In this review of CMV pneumonia, we address epidemiology, pathogenesis, diagnostics, current therapy, and strategies to prevent the development of CMV. We also review emerging treatment and prevention options for this challenging disease.

Indexed as

Antiviral AgentsCytomegalovirus InfectionsHematopoietic Stem Cell TransplantationHumansPneumonia, ViralRisk FactorsAntiviral AgentsantiviralCMV pneumoniacytomegalovirushematopoietic cell transplantprevention

Identifiers

PMID23753231
PMCPMC3775875

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.